SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddys Laboratories informs about press release

16 Sep 2020 Evaluate
Dr. Reddys Laboratories has informed that it has enclosed press release titled, ‘RDIF and Dr. Reddys to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India’.

The above information is a part of company’s filings submitted to BSE.






Dr. Reddys Labs. Share Price

1346.40 -10.45 (-0.77%)
01-Jul-2026 13:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1871.40
Dr. Reddys Labs. 1346.40
Cipla 1457.70
Zydus Lifesciences 1110.50
Lupin 2401.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: